Shandong Pharmaceutical Glass Stock Shares Owned By Insiders
| 600529 Stock | 24.48 0.22 0.91% |
Shandong Pharmaceutical Glass fundamentals help investors to digest information that contributes to Shandong Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Shandong Stock. The fundamental analysis module provides a way to measure Shandong Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Shandong Pharmaceutical stock.
Shandong |
Shandong Pharmaceutical Glass Company Shares Owned By Insiders Analysis
Shandong Pharmaceutical's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Shandong Pharmaceutical Shares Owned By Insiders | 19.51 % |
Most of Shandong Pharmaceutical's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shandong Pharmaceutical Glass is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 19.507% of Shandong Pharmaceutical Glass are shares owned by insiders. This is 41.36% higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The shares owned by insiders for all China stocks is 93.33% lower than that of the firm.
Shandong Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shandong Pharmaceutical's direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Shandong Pharmaceutical could also be used in its relative valuation, which is a method of valuing Shandong Pharmaceutical by comparing valuation metrics of similar companies.Shandong Pharmaceutical is currently under evaluation in shares owned by insiders category among its peers.
Shandong Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0661 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 13.39 B | |||
| Shares Outstanding | 663.61 M | |||
| Shares Owned By Insiders | 19.51 % | |||
| Shares Owned By Institutions | 24.94 % | |||
| Price To Book | 2.09 X | |||
| Price To Sales | 3.13 X | |||
| Revenue | 4.98 B | |||
| Gross Profit | 1.56 B | |||
| EBITDA | 1.35 B | |||
| Net Income | 775.8 M | |||
| Total Debt | 1.83 M | |||
| Book Value Per Share | 11.73 X | |||
| Cash Flow From Operations | 1.05 B | |||
| Earnings Per Share | 1.33 X | |||
| Target Price | 30.55 | |||
| Number Of Employees | 6.47 K | |||
| Beta | 0.51 | |||
| Market Capitalization | 16.07 B | |||
| Total Asset | 9.32 B | |||
| Retained Earnings | 3.58 B | |||
| Working Capital | 3.82 B | |||
| Net Asset | 9.32 B | |||
| Last Dividend Paid | 0.4 |
About Shandong Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shandong Pharmaceutical Glass's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shandong Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shandong Pharmaceutical Glass based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Shandong Stock
Shandong Pharmaceutical financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Pharmaceutical security.